1. Home
  2. GANX vs SSBI Comparison

GANX vs SSBI Comparison

Compare GANX & SSBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GANX
  • SSBI
  • Stock Information
  • Founded
  • GANX 2017
  • SSBI 1982
  • Country
  • GANX United States
  • SSBI United States
  • Employees
  • GANX N/A
  • SSBI N/A
  • Industry
  • GANX Biotechnology: Pharmaceutical Preparations
  • SSBI Major Banks
  • Sector
  • GANX Health Care
  • SSBI Finance
  • Exchange
  • GANX Nasdaq
  • SSBI Nasdaq
  • Market Cap
  • GANX 57.9M
  • SSBI 62.3M
  • IPO Year
  • GANX 2021
  • SSBI 2006
  • Fundamental
  • Price
  • GANX $1.93
  • SSBI $10.00
  • Analyst Decision
  • GANX Strong Buy
  • SSBI
  • Analyst Count
  • GANX 5
  • SSBI 0
  • Target Price
  • GANX $8.20
  • SSBI N/A
  • AVG Volume (30 Days)
  • GANX 226.2K
  • SSBI 17.9K
  • Earning Date
  • GANX 05-14-2025
  • SSBI 04-29-2025
  • Dividend Yield
  • GANX N/A
  • SSBI 0.40%
  • EPS Growth
  • GANX N/A
  • SSBI N/A
  • EPS
  • GANX N/A
  • SSBI N/A
  • Revenue
  • GANX N/A
  • SSBI $25,932,000.00
  • Revenue This Year
  • GANX N/A
  • SSBI N/A
  • Revenue Next Year
  • GANX N/A
  • SSBI N/A
  • P/E Ratio
  • GANX N/A
  • SSBI N/A
  • Revenue Growth
  • GANX N/A
  • SSBI N/A
  • 52 Week Low
  • GANX $0.89
  • SSBI $5.68
  • 52 Week High
  • GANX $3.19
  • SSBI $10.93
  • Technical
  • Relative Strength Index (RSI)
  • GANX 53.25
  • SSBI 63.18
  • Support Level
  • GANX $1.80
  • SSBI $9.60
  • Resistance Level
  • GANX $1.85
  • SSBI $10.03
  • Average True Range (ATR)
  • GANX 0.13
  • SSBI 0.26
  • MACD
  • GANX -0.00
  • SSBI 0.01
  • Stochastic Oscillator
  • GANX 60.00
  • SSBI 73.50

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

About SSBI Summit State Bank

Summit State Bank provides various banking products and services to individuals and businesses primarily in Sonoma County, California. It offers personal and business checking, money market, sweep, savings, and demand accounts; time certificates of deposit; and specialized deposit accounts, such as professional, small business packaged, tiered, and retirement plan accounts. The company also provides loans, including commercial loans and leases; lines of credit; commercial real estate, small business administration, residential mortgage, and construction loans; home equity lines of credit; and term and equipment loans, as well as loans to agriculture-related businesses.

Share on Social Networks: